Eltek (ELTK) Trading Levels Explode on Numbers, GW Pharmaceuticals

Shares of Eltek Ltd. (ELTK) skyrocketed on Wednesday's trading session after the company reported its eleventh consecutive quarter of profitability with record revenues on its financial results.

For the third quarter 2013, ELTK posted revenues of $12.8 million, compared with revenues of $10.8 million in the same period the prior year, gross profit of $2.3 million (18.3% of revenues) versus $1.7 million (16.1% of revenues) in the third quarter a year ago, and net profit of $585,000 or $0.09 per fully diluted share, compared to $135,000 or $0.02 per fully diluted share, in the third quarter of 2012.

ELTK is Israel's leading manufacturer of printed circuit boards, the core circuitry of most electronic devices. It specializes in the complex high-end of PCB manufacturing, i.e., HDI, multi-layered and flex-rigid boards. ELTK 's technologically advanced circuitry solutions are used in today's increasingly sophisticated and compact electronic products.

More about Eltek Ltd. (ELTK) at www.eltekglobal.com .

**

Multiple sclerosis is a central nervous system disease that affects millions worldwide. Although most individuals do not become severely disabled, more than half experience spasticity.

Of the estimated 400,000 people in the United States and 2.5 million worldwide with multiple sclerosis, over half suffer from spasticity

Spasticity refers to an abnormal, involuntary tightness of muscles which increases when the muscle are rapidly stretched, so that the associated joint appears to resist being moved.

As a result of the increased muscle tone due to spasticity ‘simple’ movements become difficult or impossible altogether. This restriction in movement can lead to difficulties with walking, dressing, and carrying out personal hygiene. In addition, painful muscle spasms can lead to difficulty with sleeping, sitting in a chair or lying on a bed. Occasionally spasms may be triggered by fairly minor irritations such as tight clothing, a full bladder or bowel, urinary tract infection or skin irritation, such as from a pressure sore.

The price of GW Pharmaceuticals plc (GWPH) stock soared after the company reported that it has received regulatory approval for its prescription medicine Sativex(R) in Switzerland. A full marketing authorization has been granted by the Swissmedic authorities in the treatment of moderate to severe spasticity in Multiple Sclerosis patients who have not responded adequately to other anti-spasticity medications.

Launch timing is dependent on completion of pricing and reimbursement procedures. Sativex will be commercialized in Switzerland by GWPH 's European partner, Almirall S.A.

GWPH 's Sativex is approved for use in the treatment of Multiple Sclerosis spasticity in 23 countries, including 17 countries in Europe.

GWPH is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid-product platform in a broad range of disease areas.

More about GW Pharmaceuticals plc (GWPH) at www.gwpharm.com .

**

Industries are moving all of their operations online, as it becomes clear that the Web, not constrained by geographic boundaries, is a more efficient vehicle for their services and allows them to work on a truly global scale.

Forging new relationships between businesses is becoming critical for businesses to survive and blossom in this increasingly fast paced world. Business to Business (B2B) applications provide new opportunities for businesses to leverage emerging technologies to build their businesses. Examples of B2B applications include facilitating transactions for goods/services between companies, selling goods/services on the Internet to businesses, and supply chain integration.

Looking to deliver value for its stockholders in both the near and long term, Crown Equity Holdings Inc. (CRWE) is refocusing its strategic plan to improve the potential future growth for the company, targeting the multi-billion dollar online b2b market, with its Division iB2B Global ( www.ib2bglobal.com ).

CRWE ‘s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. CRWE launches, invests and manages select businesses, projects and real estate endeavors.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com .

**

Read Full Disclaimer at www.pennyomega.com/disclaimer